These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
983 related items for PubMed ID: 10360171
1. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Mol Cell; 1999 May; 3(5):543-53. PubMed ID: 10360171 [Abstract] [Full Text] [Related]
3. Identification of a nuclear receptor for bile acids. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Science; 1999 May 21; 284(5418):1362-5. PubMed ID: 10334992 [Abstract] [Full Text] [Related]
4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Mol Endocrinol; 2003 Feb 21; 17(2):259-72. PubMed ID: 12554753 [Abstract] [Full Text] [Related]
10. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase. Matsukuma KE, Bennett MK, Huang J, Wang L, Gil G, Osborne TF. J Lipid Res; 2006 Dec 15; 47(12):2754-61. PubMed ID: 16957179 [Abstract] [Full Text] [Related]
11. Identification of DRIP205 as a coactivator for the Farnesoid X receptor. Pineda Torra I, Freedman LP, Garabedian MJ. J Biol Chem; 2004 Aug 27; 279(35):36184-91. PubMed ID: 15187081 [Abstract] [Full Text] [Related]
12. Identification of gene-selective modulators of the bile acid receptor FXR. Dussault I, Beard R, Lin M, Hollister K, Chen J, Xiao JH, Chandraratna R, Forman BM. J Biol Chem; 2003 Feb 28; 278(9):7027-33. PubMed ID: 12496277 [Abstract] [Full Text] [Related]
15. T0901317 is a dual LXR/FXR agonist. Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP. Mol Genet Metab; 2004 Feb 28; 83(1-2):184-7. PubMed ID: 15464433 [Abstract] [Full Text] [Related]
16. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. Fujino T, Une M, Imanaka T, Inoue K, Nishimaki-Mogami T. J Lipid Res; 2004 Jan 28; 45(1):132-8. PubMed ID: 13130122 [Abstract] [Full Text] [Related]
17. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Arterioscler Thromb Vasc Biol; 2007 Dec 28; 27(12):2606-11. PubMed ID: 18029909 [Abstract] [Full Text] [Related]
18. FXR: a metabolic regulator and cell protector. Wang YD, Chen WD, Moore DD, Huang W. Cell Res; 2008 Nov 28; 18(11):1087-95. PubMed ID: 18825165 [Abstract] [Full Text] [Related]
19. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. Deng R, Yang D, Yang J, Yan B. J Pharmacol Exp Ther; 2006 Apr 28; 317(1):317-25. PubMed ID: 16371446 [Abstract] [Full Text] [Related]
20. Role of FXR in regulating bile acid homeostasis and relevance for human diseases. Rizzo G, Renga B, Mencarelli A, Pellicciari R, Fiorucci S. Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep 28; 5(3):289-303. PubMed ID: 16178789 [Abstract] [Full Text] [Related] Page: [Next] [New Search]